Immunotherapy for Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 67302
Special Issue Editors
Interests: gastrointestinal tumors; translational research; clinical trials
Special Issues, Collections and Topics in MDPI journals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Various research studies have focused on many of the immunological approaches for cancer treatment. Current therapies for cancer are ineffective, with unacceptably high toxicity, and most of them have severe side effects on the patients. Among some of the most common treatments for cancer, immunotherapy is a potential and promising treatment strategy for various forms of cancer. Nevertheless, there are challenges that researchers and doctors should consider. Immune checkpoint inhibitors (ICIs), bi-specific T-cell engagers (BiTEs), and chimeric antigen receptor T cell (CAR-T cells) are the most effective methods for cancer therapy. Recently, researchers have been considering the potential of a combination therapy based on the aforementioned methods, which in some cases has been shown to have a much greater effect on cancer therapy. Novel research strategies are therefore required for a better description of the mechanisms of these approaches for cancer therapy.
The focus of this Special Issue is to consider the following research aspects summarized below: a) Novel immune checkpoint targets; b) clinical experience with bi-specific T Cell engagers; c) chimeric antigen receptor (CAR) T-Cell therapy; and d) immuno-oncology combination therapy.
Dr. Nicola Silvestris
Dr. Afshin Derakhshani
Dr. Oronzo Brunetti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.